16-78425054-C-T
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_016373.4(WWOX):c.790C>T(p.Arg264*) variant causes a stop gained, splice region change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000112 in 1,613,428 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_016373.4 stop_gained, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
WWOX | NM_016373.4 | c.790C>T | p.Arg264* | stop_gained, splice_region_variant | 7/9 | ENST00000566780.6 | NP_057457.1 | |
WWOX | NM_001291997.2 | c.451C>T | p.Arg151* | stop_gained, splice_region_variant | 6/8 | NP_001278926.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
WWOX | ENST00000566780.6 | c.790C>T | p.Arg264* | stop_gained, splice_region_variant | 7/9 | 1 | NM_016373.4 | ENSP00000457230.1 |
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152136Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000160 AC: 4AN: 249516Hom.: 0 AF XY: 0.0000148 AC XY: 2AN XY: 135366
GnomAD4 exome AF: 0.0000109 AC: 16AN: 1461292Hom.: 0 Cov.: 32 AF XY: 0.0000138 AC XY: 10AN XY: 726982
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152136Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74310
ClinVar
Submissions by phenotype
Developmental and epileptic encephalopathy, 28 Pathogenic:2
Pathogenic, criteria provided, single submitter | clinical testing | Centre de Biologie Pathologie Génétique, Centre Hospitalier Universitaire de Lille | - | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Institute of Medical Genetics and Genomics, Sir Ganga Ram Hospital | Oct 19, 2023 | This homozygous termination variant is identified in a 9 months male with GDD, refractory seizures, severe failure to thrive, spasticity in both upper limbs and abnormal EEG. This nucleotide change is present in gnomAD database with a low allele frequency of 0.0011% [PM2]. Insilico prediction [MutationTaster] predicts a deleterious nature of this variant [PP3]. A clinvar entry [Variation id: 241105] of this variant is already present with a "Pathogenic" interpretation [PP5]. Based on the clinical correlation and available evidence, this variant is classified as "Pathogenic" - |
Malignant tumor of esophagus;C3280452:Autosomal recessive spinocerebellar ataxia 12;C4015519:Developmental and epileptic encephalopathy, 28 Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Sep 20, 2021 | - - |
Autosomal recessive spinocerebellar ataxia 12;C3463992:Developmental and epileptic encephalopathy, 1 Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 20, 2023 | This sequence change creates a premature translational stop signal (p.Arg264*) in the WWOX gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in WWOX are known to be pathogenic (PMID: 24456803, 25411445). This variant is present in population databases (rs756762196, gnomAD 0.007%). This variant has not been reported in the literature in individuals affected with WWOX-related conditions. ClinVar contains an entry for this variant (Variation ID: 241105). For these reasons, this variant has been classified as Pathogenic. - |
WWOX-related disorder Pathogenic:1
Pathogenic, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Apr 29, 2024 | The WWOX c.790C>T variant is predicted to result in premature protein termination (p.Arg264*). This variant has been reported in the homozygous state in individuals with WWOX-related epileptic encephalopathy (Supplemental Table 1, Piard et al 2019. PubMed ID: 30356099; Iacomino M et al 2020. PubMed ID: 32581702) and the heterozygous state in individuals with epilepsy (Supplemental Table 2, Truty R et al 2019. PubMed ID: 31440721). This variant is reported in 0.0065% of alleles in individuals of South Asian descent in gnomAD. Nonsense variants in WWOX are expected to be pathogenic. This variant is interpreted as pathogenic. - |
not provided Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Aug 10, 2015 | The R264X variant in the WWOX gene has not been reported previously as a germline pathogenic variant nor as a benign polymorphism, to our knowledge. This variant is predicted to cause loss of normal protein function either through protein truncation or nonsense-mediated mRNA decay. The R264X variant was not observed in approximately 6,100 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. We interpret R264X as a pathogenic variant. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at